Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Patients’ baseline disease characteristics<br />
Placebo<br />
(MTX only)<br />
(n=204)<br />
Tocilizumab<br />
4 mg/kg + MTX<br />
(n=213)<br />
Tocilizumab<br />
8 mg/kg + MTX<br />
(n=205)<br />
Disease duration (mean, yrs)<br />
7.8<br />
7.4<br />
7.5<br />
SJC (mean)<br />
20.7<br />
20.0<br />
19.5<br />
TJC (mean)<br />
32.8<br />
33.2<br />
31.9<br />
CRP (mean, mg/dL)<br />
2.36<br />
2.79<br />
2.61<br />
ESR (mean, mm/h)<br />
49.7<br />
49.2<br />
51.2<br />
DAS28 (mean)<br />
6.82<br />
6.78<br />
6.82<br />
19